Cancers of the Head and Neck Active Not Recruiting Phase 2 Trials for Cetuximab (DB00002)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270814Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaTreatment
NCT02573493Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)Treatment